From Nasdaq, Inc.:

In a recent video, four healthcare stocks were reviewed, including Humana (NYSE: HUM), published on Jan. 16, 2024. The article also discusses whether investors should buy Humana stock and mentions that it was not identified among the 10 best stocks by The Motley Fool Stock Advisor. Stock Advisor provides guidance and has more than tripled the return of S&P 500 since 2002. Neil Rozenbaum has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends AbCellera Biologics, with a disclosure policy stated.



Read more: 4 Magnificent Healthcare Stocks to Buy in 2024 and Beyond